921
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine

, , , , , , , , ORCID Icon, , , , & show all

References

  • Grohskopf LA, Sokolow LZ, Fry AM, Walter EB, Jernigan DB. Update: ACIP recommendations for the use of quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018–19 influenza season. MMWR Morb Mortal Wkly Rep. 2018;67:643–45. doi:10.15585/mmwr.mm6722a5.
  • Campbell AJP, Grohskopf LA. Updates on influenza vaccination in children. Infect Dis Clin North Am. 2018;32:75–89. doi:10.1016/j.idc.2017.11.005.
  • Committee on Infectious D. Recommendations for prevention and control of influenza in children, 2017–2018. Pediatrics. 2017:140(4):e20172550.
  • D’Angio CT, Heyne RJ, Duara S, Holmes LC, O’Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, et al. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J. 2011;30:570–74. doi:10.1097/INF.0b013e31820c1fdf.
  • Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter A-L, Gubbay JB, Krajden M, et al. Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One. 2014;9:e92153. doi:10.1371/journal.pone.0092153.
  • Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J. 2010;29:105–10. doi:10.1097/INF.0b013e3181b84c34.
  • Baxter R, Jeanfreau R, Block SL, Blatter M, Pichichero M, Jain VK, Dewé W, Innis BL. A phase III evaluation of immunogenicity and safety of two trivalent inactivated seasonal influenza vaccines in US children. Pediatr Infect Dis J. 2010;29:924–30. doi:10.1097/INF.0b013e3181e075be.
  • Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, Nissen M, Marshall H, Booy R, Heron L, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA. 2010;303:37–46. doi:10.1001/jama.2009.1911.
  • Bodewes R, Kreijtz JH, Rimmelzwaan GF. Yearly influenza vaccinations: a double-edged sword? Lancet Infect Dis. 2009;9:784–88. doi:10.1016/S1473-3099(09)70263-4.
  • Cao RG, Suarez NM, Obermoser G, Lopez SM, Flano E, Mertz SE, Albrecht RA, García-Sastre A, Mejias A, Xu H, et al. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J Infect Dis. 2014;210:224–33. doi:10.1093/infdis/jiu079.
  • Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, Nino D, Arden N, Quarles JM, Couch RB, Belmont JW, et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis. 2011;203:921–29. doi:10.1093/infdis/jiq156.
  • Tan Y, Tamayo P, Nakaya H, Pulendran B, Mesirov JP, Haining WN. Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response. Eur J Immunol. 2014;44:285–95. doi:10.1002/eji.201343657.
  • Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, Frasca D, Gersten M, Mehta A, Gaujoux R, et al. Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity. 2015;43:1186–98. doi:10.1016/j.immuni.2015.11.012.
  • Hoek KL, Samir P, Howard LM, Niu X, Prasad N, Galassie A, Liu Q, Allos TM, Floyd KA, Guo Y, et al. A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination. PLoS One. 2015;10:e0118528. doi:10.1371/journal.pone.0118528.
  • Henn AD, Wu S, Qiu X, Ruda M, Stover M, Yang H, Liu Z, Welle SL, Holden-Wiltse J, Wu H, et al. High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature. Sci Rep. 2013;3:2327. doi:10.1038/srep02327.
  • Zhu W, Higgs BW, Morehouse C, Streicher K, Ambrose CS, Woo J, Kemble GW, Jallal B, Yao Y. A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children. Vaccine. 2010;28:2865–76. doi:10.1016/j.vaccine.2010.01.060.
  • Kim JH, Mishina M, Chung JR, Cole KS, Nowalk MP, Martin JM, Spencer S, Flannery B, Zimmerman RK, Sambhara S, et al. Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season. J Infect Dis. 2016;214:1030–38. doi:10.1093/infdis/jiw311.
  • Cole KS, Martin JM, Horne WT, Lin CJ, Nowalk MP, Alcorn JF, Zimmerman RK. Differential gene expression elicited by children in response to the 2015–16 live attenuated versus inactivated influenza vaccine. Vaccine. 2017;35:6893–97. doi:10.1016/j.vaccine.2017.09.019.
  • Russell K, Blanton L, Kniss K, Mustaquim D, Smith S, Cohen J, Garg S, Flannery B, Fry AM, Grohskopf LA, et al. Update: influenza activity–united States, October 4, 2015-February 6, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:146–53. doi:10.15585/mmwr.mm6506a3.
  • WHO Global Influenza Surveillance Network. Serological diagnosis of influenza by haemagglutination inhibition testing. In: Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva (Switzerland): World Health Organization; 2011.
  • Manni ML, Trudeau JB, Scheller EV, Mandalapu S, Elloso MM, Kolls JK, Wenzel SE, Alcorn JF. The complex relationship between inflammation and lung function in severe asthma. Mucosal Immunol. 2014;7:1186–98. doi:10.1038/mi.2014.8.
  • Martin JM, Avula R, Nowalk MP, Lin CJ, Horne WT, Chandran UR, Avula R, Nagg JP, Zimmerman RK, Cole KS, et al. Inflammatory mediator expression associated with antibody response induced by live attenuated vs inactivated influenza virus vaccine in children. Open Forum Infect Dis. 2018;5:ofy277. doi:10.1093/ofid/ofy277.
  • Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci USA. 2014;111:869–74. doi:10.1073/pnas.1321060111.
  • Kurupati R, Kossenkov A, Haut L, Kannan S, Xiang Z, Li Y, Doyle S, Liu Q, Schmader K, Showe L, et al. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood. Oncotarget. 2016;7:62898–911. doi:10.18632/oncotarget.v7i39.
  • Thakar J, Mohanty S, West AP, Joshi SR, Ueda I, Wilson J, Meng H, Blevins TP, Tsang S, Trentalange M, et al. Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging (Albany NY). 2015;7:38–52. doi:10.18632/aging.v7i1.
  • Wang Z, Gerstein M, Snyder M. RNA-seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57–63. doi:10.1038/nrg2484.
  • Zhao S, Fung-Leung WP, Bittner A, Ngo K, Liu X, Zhang S-D. Comparison of RNA-seq and microarray in transcriptome profiling of activated T cells. PLoS One. 2014;9:e78644. doi:10.1371/journal.pone.0078644.
  • Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, Warshawsky BF. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med. 2019;17:9. doi:10.1186/s12916-018-1239-8.
  • Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008;3:e2975. doi:10.1371/journal.pone.0002975.
  • Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB. Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults. Clin Vaccine Immunol. 2017;24:e00414-16.
  • Jang H, Ross TM. Preexisting influenza specific immunity and vaccine effectiveness. Expert Rev Vaccines. 2019;18:1043–51. doi:10.1080/14760584.2019.1675519.
  • Lewnard JA, Cobey S. Immune history and influenza vaccine effectiveness. Vaccines (Basel). 2018;6(2):E28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.